Drug intelligence / Profile preview

fentanyl + dexmedetomidine (University of Saskatchewan)

Development stage
Unknown
Lead developer
University of Saskatchewan
Modality
Small Molecules
Administration
Intravenous
01

Overview

Fentanyl + dexmedetomidine is a pharmacological combination used for anesthesia and analgesia. Fentanyl is a potent synthetic opioid that acts as a mu-opioid receptor agonist, providing rapid-onset pain relief. Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist that provides sedation, anxiolysis, and supplemental analgesia with minimal respiratory depression. In a clinical trial conducted by the University of Saskatchewan, this combination was evaluated as a standard-of-care control regimen in children with sleep-disordered breathing or obstructive sleep apnea undergoing tonsillectomy to compare its effects on postoperative respiratory depression against an opioid-free anesthetic protocol.

Other names
fentanyl and dexmedetomidine
02

Targets

ADRA2C (α2C)MOR (Mu opioid receptor)ADRA2B (α2B)ADRA2A (α2A)

Beyond the preview

Go deeper on fentanyl + dexmedetomidine (University of Saskatchewan).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentanyl + dexmedetomidine (University of Saskatchewan).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call